- Lenvatinib, trade name: Lenvima
- Lenvatinib is suitable for the treatment of patients with locally recurring or metastatic, progressive, radioiodine-refractory differentiated thyroid cancer.
[ Disclaimer: The APIs are used for production of drug products. DO NOT USE DIRECTLY FOR PATIENTS. ]
